These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 18546078)
21. The role of inflammation in the pathophysiology of CF lung disease. Chmiel JF; Berger M; Konstan MW Clin Rev Allergy Immunol; 2002 Aug; 23(1):5-27. PubMed ID: 12162106 [TBL] [Abstract][Full Text] [Related]
25. Emerging therapies in cystic fibrosis. Anderson P Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065 [TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators. Perrem L; Ratjen F Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088 [TBL] [Abstract][Full Text] [Related]
33. An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line. Sheikh Z; Bradbury P; Pozzoli M; Young PM; Ong HX; Traini D Eur J Pharm Biopharm; 2020 Nov; 156():121-130. PubMed ID: 32916267 [TBL] [Abstract][Full Text] [Related]
34. Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. Sheikh Z; Bradbury P; Reekie TA; Pozzoli M; Robinson PD; Kassiou M; Young PM; Ong HX; Traini D Eur J Pharmacol; 2021 Jul; 902():174098. PubMed ID: 33848541 [TBL] [Abstract][Full Text] [Related]
35. Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations. Scott LK; Toner R Lung; 2017 Aug; 195(4):397-401. PubMed ID: 28623538 [TBL] [Abstract][Full Text] [Related]
36. Pathophysiology and management of pulmonary infections in cystic fibrosis. Gibson RL; Burns JL; Ramsey BW Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458 [TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics. Kunzelmann K; Mall M Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996 [TBL] [Abstract][Full Text] [Related]
38. Inflammation in cystic fibrosis--when and why? Friend or foe? Elston C; Geddes D Semin Respir Crit Care Med; 2007 Jun; 28(3):286-94. PubMed ID: 17562498 [TBL] [Abstract][Full Text] [Related]
39. Treatment strategies for cystic fibrosis: what's in the pipeline? Frerichs C; Smyth A Expert Opin Pharmacother; 2009 May; 10(7):1191-202. PubMed ID: 19405793 [TBL] [Abstract][Full Text] [Related]
40. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Boucher RC Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]